References for: association

Full identifier: http://purl.org/np/RAByRo_QWumOmTIjTm2dsTeamvbatSCuVDKaJ-BlJSCLg#association

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-05-19T19:35:28.681Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-05-19T19:35:28.681Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-05-19T19:35:28.681Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-05-19T19:35:28.681Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-05-19T19:35:28.681Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-05-19T19:35:28.681Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-05-19T19:35:28.681Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Based on available data, clonazepam may represent a treatment option in children with arousal disorders (parasomnias) or periodic leg movement disorder or restless legs syndrome (RLS), but future trials focused on objective sleep measures and safety issues are needed.
0000-0002-7641-6446
2021-05-19T19:35:28.681Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-05-19T19:35:28.681Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
0000-0002-7641-6446
2021-05-19T19:35:28.681Z